Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. MarketLine, a Progressive Digital Media business.
Chicago Style (17th ed.) CitationTransition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. MarketLine, a Progressive Digital Media business.
MLA (8th ed.) CitationTransition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. MarketLine, a Progressive Digital Media business.
Warning: These citations may not always be 100% accurate.